Highlights the historical shift in understanding heart failure progression as a hormonally mediated structural remodeling process that can be inhibited by specific drug therapies.
No takes yet. Share an insight, caveat, or question.
Supports hormonally mediated remodeling inhibition in heart failure; leaves open optimal agent selection for long-term outcomes.
Jay N. Cohn (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: